Access to allogeneic hematopoietic SCT for patients with MDS or relapsed AML treated according to protocols of the Dutch Childhood Oncology Group.
about
Access to allogeneic hematopoietic SCT for patients with MDS or relapsed AML treated according to protocols of the Dutch Childhood Oncology Group.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Access to allogeneic hematopoi ...... utch Childhood Oncology Group.
@en
Access to allogeneic hematopoi ...... utch Childhood Oncology Group.
@nl
type
label
Access to allogeneic hematopoi ...... utch Childhood Oncology Group.
@en
Access to allogeneic hematopoi ...... utch Childhood Oncology Group.
@nl
prefLabel
Access to allogeneic hematopoi ...... utch Childhood Oncology Group.
@en
Access to allogeneic hematopoi ...... utch Childhood Oncology Group.
@nl
P2093
P2860
P356
P1476
Access to allogeneic hematopoi ...... utch Childhood Oncology Group.
@en
P2093
F H J Claas
J J van Rood
M B Bierings
M Oudshoorn
R M Egeler
P2860
P2888
P304
P356
10.1038/BMT.2011.168
P407
P577
2011-08-22T00:00:00Z
P5875
P6179
1022257787